Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
What's New
Your Valuation
Loading...
Community
/
Denmark
/
Materials
/
Novozymes
Create a narrative
Novozymes Community
CPSE:NSIS B Community
0
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Community Investing Ideas
Novozymes
Popular
Undervalued
Overvalued
There are no community narratives available.
Recently
Updated Narratives
OS
oscargarcia
on Mastercard
·
Updated
about 1 hour ago
A fortress-like financial tech company riding global digital payments and fintech innovation waves
Fair Value:
US$520
2.0% overvalued
intrinsic discount
11
followers
users have followed this narrative
·
0
comments
users have commented on this narrative
·
0
likes
users have liked this narrative
OS
oscargarcia
on NVIDIA
·
Updated
about 3 hours ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
Fair Value:
US$230
18.9% undervalued
intrinsic discount
63
followers
users have followed this narrative
·
9
comments
users have commented on this narrative
·
1
like
users have liked this narrative
WA
Wane_Investment_House
on Champion Breweries
·
Updated
about 20 hours ago
CHAMPION BREWERIES PLC Q3 Result – Earnings Rebound Driven by Strong Volume Growth Amid Rising Finance Costs and Working Capital Expansion
Fair Value:
₦15
8.7% undervalued
intrinsic discount
13
followers
users have followed this narrative
·
6
comments
users have commented on this narrative
·
0
likes
users have liked this narrative
Popular Narratives
OS
oscargarcia
on Alphabet
·
Updated
5 days ago
The company that turned a verb into a global necessity and basically runs the modern internet, digital ads, smartphones, maps, and AI.
Fair Value:
US$340
13.9% undervalued
intrinsic discount
120
followers
users have followed this narrative
·
5
comments
users have commented on this narrative
·
15
likes
users have liked this narrative
AN
AnalystConsensusTarget
on NVIDIA
·
Updated
5 days ago
NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026
Fair Value:
US$232.79
19.9% undervalued
intrinsic discount
908
followers
users have followed this narrative
·
5
comments
users have commented on this narrative
·
21
likes
users have liked this narrative
AM
AmirV
on Paradigm Biopharmaceuticals
·
Updated
about 2 months ago
Paradigm Biopharmaceuticals Will Lead Osteoarthritis Treatment with Zilosul's FDA Success
Fair Value:
AU$5.5
94.2% undervalued
intrinsic discount
68
followers
users have followed this narrative
·
3
comments
users have commented on this narrative
·
18
likes
users have liked this narrative
Your Valuation for
NSIS B
NSIS B
Novozymes
Your Fair Value
DKK
Current Price
DKK 399.30
34.1% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
6b
2015
2018
2021
2024
2025
2027
2030
Revenue €5.7b
Earnings €751.9m
Advanced
Set Fair Value